Barclays’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-190,332
Closed -$4.5M 5448
2023
Q4
$4.5M Buy
190,332
+146,694
+336% +$2.61M ﹤0.01% 2188
2023
Q3
$651K Sell
43,638
-10,603
-20% -$141K ﹤0.01% 2633
2023
Q2
$594K Buy
54,241
+27,265
+101% +$254K ﹤0.01% 2645
2023
Q1
$235K Sell
26,976
-20,799
-44% -$167K ﹤0.01% 3694
2022
Q4
$300K Buy
47,775
+42,722
+845% +$162K ﹤0.01% 3627
2022
Q3
$18K Sell
5,053
-129,900
-96% -$467K ﹤0.01% 4106
2022
Q2
$398K Buy
134,953
+93,054
+222% +$222K ﹤0.01% 3025
2022
Q1
$130K Sell
41,899
-42,228
-50% -$133K ﹤0.01% 3669
2021
Q4
$285K Buy
84,127
+55,795
+197% +$212K ﹤0.01% 3439
2021
Q3
$104K Buy
28,332
+19,348
+215% +$76.2K ﹤0.01% 3888
2021
Q2
$40K Sell
8,984
-49,330
-85% -$219K ﹤0.01% 4236
2021
Q1
$264K Buy
58,314
+35,694
+158% +$192K ﹤0.01% 3578
2020
Q4
$129K Sell
22,620
-9,119
-29% -$69K ﹤0.01% 4011
2020
Q3
$230K Sell
31,739
-87,062
-73% -$466K ﹤0.01% 3755
2020
Q2
$415K Sell
118,801
-19,218
-14% -$55.5K ﹤0.01% 3488
2020
Q1
$204K Buy
138,019
+62,598
+83% +$105K ﹤0.01% 4281
2019
Q4
$149K Sell
75,421
-727,331
-91% -$2.73M ﹤0.01% 5237
2019
Q3
$4.11M Buy
802,752
+401,778
+100% +$2.43M 0.01% 2025
2019
Q2
$2.87M Buy
400,974
+337,927
+536% +$3.83M ﹤0.01% 2485
2019
Q1
$837K Buy
63,047
+59,700
+1,784% +$635K ﹤0.01% 3610
2018
Q4
$26K Sell
3,347
-52,933
-94% -$504K ﹤0.01% 5788
2018
Q3
$624K Buy
56,280
+51,957
+1,202% +$645K ﹤0.01% 4079
2018
Q2
$58K Sell
4,323
-84,064
-95% -$1.05M ﹤0.01% 5574
2018
Q1
$1.15M Sell
88,387
-49,173
-36% -$611K ﹤0.01% 3038
2017
Q4
$1.26M Buy
137,560
+124,310
+938% +$1.06M ﹤0.01% 2871
2017
Q3
$107K Sell
13,250
-1,509
-10% -$10.2K ﹤0.01% 4884
2017
Q2
$85K Buy
+14,759
New +$62.8K ﹤0.01% 5034
2016
Q4
Sell
-11,500
Closed -$22K 6919
2016
Q3
$22K Buy
+11,500
New +$22.9K ﹤0.01% 5434
2016
Q2
Sell
-1,300
Closed -$1K 6728
2016
Q1
$1K Buy
+1,300
New +$1.61K ﹤0.01% 6024
2014
Q4
Sell
-2,400
Closed -$14K 7691
2014
Q3
$14K Buy
+2,400
New +$14.7K ﹤0.01% 6708

Other funds holding CBAY